Hollis, Kelly
Proctor, Christina
McBride, Doreen
Balp, Maria-Magdalena
McLeod, Lori
Hunter, Shannon
Tian, Haijun
Khalil, Sam
Maurer, Marcus
Funding for this research was provided by:
Novartis Pharma
Article History
First Online: 24 January 2018
Compliance with Ethical Standards
:
: KH, DMcB, LMcL, SH are employed by RTI Health Solutions and as salaried employees did not receive direct compensation from the sponsor. CP was employed by RTI Health Solutions as a salaried employee at the time of the study. In their salaried positions, they work(ed) with a variety of companies and organizations and do not receive direct payments from any company or organization. RTI Health Solutions is a research unit of RTI International, a US not-for profit research Institute, and received consultancy fees from Novartis Pharma AG for this work. RTI Health Solutions and Novartis were involved in the analysis and interpretation of data and the decision to submit these data for publication. MMB and SK are employees of Novartis Pharma AG, who funded the study and the manuscript. HT is an employee of Novartis Pharmaceuticals Corporation, and owns stock from Novartis Pharmaceuticals Corporation. MM is, or recently was, a speaker and/or advisor, and/or received research funding from Novartis.
: This study was funded by Novartis Pharma AG, Basel, Switzerland.